The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital



Download Doherty Institute brochures and capacity statements

Overview of the Doherty Institute

Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort.


Doherty Applied Microbial Genomics capacity statement

Doherty Applied Microbial Genomics was established to facilitate research directed towards implementing microbial genomics within public health and clinical microbiology practice in Australia. The centre is funded by The University of Melbourne and houses technology that uses next-generation DNA sequencing, providing unparalleled speed and accuracy to genetically identify and track disease-causing microbes.


Hepatitis B capacity statement

HBV is a major focus for the Peter Doherty Institute for Infection and Immunity (Doherty Institute), with a broad spectrum of activities spanning public health, discovery research and clinical care.


Influenza capacity statement

Influenza is a virus that causes respiratory infection and infects five to 10 per cent of adults globally each year. This is called seasonal influenza and usually occurs in the winter months. Influenza is a major focus for the Doherty Institute, with a broad spectrum of activities spanning surveillance, epidemiology and discovery research.